Thu. Aug 5th, 2021

National Medicine Policy to be announced in next two weeks: Dr Zafar

Advisor to the Prime Minister on National Health Dr Zafar Mirza on Wednesday said that the government has already completed work on National Medicine Policy aimed at reforming the pharmaceutical industry of the country which would be announced in next two weeks.  

Addressing at 5th Pharma Summit organized by the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) here, the Advisor said that besides the National Medicine Policy, five year action plan was also devised for its implementation.

He went on to say that regulatory system was also being made predictable and easy for growing the pharma sector in the country.

The Advisor said the government was committed to reforming the pharm sector and all bottle necks were being removed in this regard.

He also conceded that there were more difficulties due to presence of interest groups.

Dr Mirza said efforts were also being made that only best possible people could run the regulatory authority.

The Advisor also urged the pharma sector to shun practice of unethical promotion of their certain products.

Earlier, speaking on the occasion, Advisor to the Prime Minister on Commerce Abdul Razak Dawood said the government was committed to increasing the country’s exports by removing all the obstacles and roadblocks. Special focus was also being given to increase the exports’ volume through tariff rationalization, trade related investment, institutional reforms and easing of business regulations, he added.

He said textile was leading export of the country but now new sectors including pharma were identified which could enhance the country’s exports.

He said pharma industry was very important for us and strategy was being developed to reform it for enhancing pharma exports. Abdul Razak Dawood said that African countries have around 1.3 billion populations with $ 2.7 trillion GDP and the government also wanted to double our trade with them in next five years.

He urged the pharma sector to look towards African countries for capturing their markets.

The Advisor said revitalizing the exports of the pharma sector was one of the government priorities to boost the national exchequer. A special pharmaceutical export promotion committee has also been set up to encourage production and exports of medicines and medical products, he added.  

He called upon the pharma industry to come forward in order to enhance the current volume of over $ 300 million exports to over $ 3 billion.

He said, “ We are debt crisis and it can be get rid off owing to export and export only.”  

The Advisor also lauded the PPMA for organizing the Summit.

Earlier, in his opening remarks, Chairman PPMA Mian Zaka ur Rehman said that Pakistan has a strongest pharma industry in all Muslim countries and 98 per cent of country requirement was being fulfilled locally. The pharma sector has witnessed 20 per cent growth in last two year, he said and added that we could fulfill the requirement of whole region as Allah Almighty blessed us with raw materials being used in manufacturing medicines.

He said there were tremendous opportunities for pharma sector to export their products in African countries.    

 He said the summit would discuss in detail issues related to functioning, regulation, control, growth, and advancement of the Pakistani pharmaceutical industry.

Former State Minister and ECO Trade Development Authority of Pakistan, Tariq Ikram said Pakistan has rich potential to export phamra products to the other countries. The current export volume of phama sector could easily be enhanced to $ 5.4 billion from $ 300 million, he added.  

Prof Dr Zaheer-ud-Din Babar, Professor of Medicines and Healthcare at the University of Huddersfield, Chairman of the Summit  Dr Kaiser Waheed and notable of the Pakistani pharmaceutical industry Ali Akhai, Khalid Mahmood , Javed Gulam Mohammad, Zahid Saeed, Osman Khalid Waheed, Nusrat Munshi, Hamid Raza, Haroon Qassim, Dr Shahzad Khan, Dr Uzair Nagra and others also spoke on the occasion and highlighted the issue and challenges to the pharma industries.

It is pertinent to mention here that the title of this year’s summit was “Mastering innate strengths and acquiring new capabilities”.